Danaher Corporation

DHR
NYSE
Last Updated: 1/23/2022 5:54:56 PM
Price
280.45
Changes
-2.51
% Change
-0.89
Volume
4016213
52 Week
High
333.96
52 Week
Low
211.22
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Danaher Corporation Company Details
CEO:   Mr. Thomas Joyce
Country:   US
Industry:   Diagnostics & Research
Website:   https://www.danaher.com
Exchange:   New York Stock Exchange
IPO\Launch Date:   1969-12-10
Danaher Corporation Company Executive Details
  Mr. Joakim Weidemanis
  Executive Vice President
  Ms. Angela S. Lalor
  Senior Vice President of HR
  Mr. Brian W. Ellis
  Senior Vice President, Gen. Counsel & Chief Compliance Officer
  Mr. Matthew R. McGrew
  Chief Financial Officer & Executive Vice President
  Mr. Rainer M. Blair
  Pres, Chief Executive Officer & Director

Danaher Corporation Latest News

Down 11.8% in 4 Weeks, Here's Why Danaher (DHR) Looks Ripe for a Turnaround


Danaher (DHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.


Published on: 2022-01-21 11:35:19

Impact on Symbol / Company: DHR

View News

ETY: A Solid Income Play


ETY: A Solid Income Play


Published on: 2022-01-18 23:07:52

Impact on Symbol / Company: DHR

View News

Danaher (DHR) Q4 Sales to Exceed Guidance on Healthy Demand


Danaher (DHR) communicates that its fourth-quarter 2021 sales performance is better than previously expected as solid demand in all three segments drives the performance.


Published on: 2022-01-12 13:07:17

Impact on Symbol / Company: DHR

View News

Danaher Corporation (DHR) CEO Rainer Blair Presents At JPMorgan 40th Annual Healthcare Conference (Transcript)


Danaher Corporation (DHR) CEO Rainer Blair Presents At JPMorgan 40th Annual Healthcare Conference (Transcript)


Published on: 2022-01-11 13:25:18

Impact on Symbol / Company: DHR

View News

Danaher says Q4 revenue growth will exceed its guidance, stock climbs premarket


Danaher Corp. DHR, +2.49% said Tuesday it expects fourth-quarter core revenue growth to exceed its own guidance, boosted by better-than-expected results at all three of its operating segments. The life sciences company is ow expecting revenue to grow in a high teens to low-twenties percentage range from the year-earlier period.


Published on: 2022-01-11 06:41:16

Impact on Symbol / Company: DHR

View News

Jim Cramer's charitable trust bought stocks during Monday's weakness. Here's why


"When an important index like the Nasdaq trades at a three-month low, you have to at least buy something that's being thrown out," the "Mad Money" host said.


Published on: 2022-01-10 18:18:51

Impact on Symbol / Company: DHR

View News

Danaher To Present At J.P. Morgan Healthcare Conference


WASHINGTON, Jan. 4, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.


Published on: 2022-01-04 16:15:00

Impact on Symbol / Company: DHR

View News

We're buying more Danaher shares, trimming our position in this volatile credit card stock


Following the trades, the Charitable Trust will own 175 shares of Danaher and 250 shares of Mastercard.


Published on: 2022-01-04 12:33:02

Impact on Symbol / Company: DHR

View News

Danaher (DHR) Gains As Market Dips: What You Should Know


Danaher (DHR) closed the most recent trading day at $329.01, moving +0.16% from the previous trading session.


Published on: 2021-12-31 19:06:19

Impact on Symbol / Company: DHR

View News

Here's Why Danaher (DHR) Is a Worthy Investment Pick for 2022


Danaher (DHR) seems a good pick for 2022. It boasts segmental opportunities, buyout-led gains, solid product offerings and a focus on innovation.


Published on: 2021-12-31 10:43:13

Impact on Symbol / Company: DHR

View News

5 S&P 500 Stocks That Helped the Index Score Big in 2021


NVIDIA (NVDA), Danaher (DHR), Rockwell (ROK), Gartner (IT) and Ingersoll Rand (IR) are some of the top S&P 500 stocks that outperformed the index in 2021.


Published on: 2021-12-30 09:58:22

Impact on Symbol / Company: DHR

View News

DANAHER SCHEDULES FOURTH QUARTER 2021 EARNINGS CONFERENCE CALL


WASHINGTON, Dec. 27, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2021 on Thursday, January 27, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.


Published on: 2021-12-27 16:15:00

Impact on Symbol / Company: DHR

View News

Grow your Money

We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures

Services we Offer

We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others

Live Market Data

We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you